Cargando…

Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021

The rate of SARS-CoV-2 infections in children remains unclear due to many asymptomatic cases. We present a study of cross-sectional seroprevalence surveys of anti-SARS-CoV-2 IgG in 10,358 children recruited in paediatric hospitals across Germany from June 2020 to May 2021. Seropositivity increased f...

Descripción completa

Detalles Bibliográficos
Autores principales: Sorg, Anna-Lisa, Bergfeld, Leon, Jank, Marietta, Corman, Victor, Semmler, Ilia, Goertz, Anna, Beyerlein, Andreas, Verjans, Eva, Wagner, Norbert, Von Bernuth, Horst, Lander, Fabian, Weil, Katharina, Hufnagel, Markus, Spiekerkoetter, Ute, Chao, Cho-Ming, Naehrlich, Lutz, Muntau, Ania Carolina, Schulze-Sturm, Ulf, Hansen, Gesine, Wetzke, Martin, Jung, Anna-Maria, Niehues, Tim, Fricke-Otto, Susanne, Von Both, Ulrich, Huebner, Johannes, Behrends, Uta, Liese, Johannes G., Schwerk, Christian, Drosten, Christian, Von Kries, Ruediger, Schroten, Horst
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170697/
https://www.ncbi.nlm.nih.gov/pubmed/35668073
http://dx.doi.org/10.1038/s41467-022-30482-6
_version_ 1784721492969259008
author Sorg, Anna-Lisa
Bergfeld, Leon
Jank, Marietta
Corman, Victor
Semmler, Ilia
Goertz, Anna
Beyerlein, Andreas
Verjans, Eva
Wagner, Norbert
Von Bernuth, Horst
Lander, Fabian
Weil, Katharina
Hufnagel, Markus
Spiekerkoetter, Ute
Chao, Cho-Ming
Naehrlich, Lutz
Muntau, Ania Carolina
Schulze-Sturm, Ulf
Hansen, Gesine
Wetzke, Martin
Jung, Anna-Maria
Niehues, Tim
Fricke-Otto, Susanne
Von Both, Ulrich
Huebner, Johannes
Behrends, Uta
Liese, Johannes G.
Schwerk, Christian
Drosten, Christian
Von Kries, Ruediger
Schroten, Horst
author_facet Sorg, Anna-Lisa
Bergfeld, Leon
Jank, Marietta
Corman, Victor
Semmler, Ilia
Goertz, Anna
Beyerlein, Andreas
Verjans, Eva
Wagner, Norbert
Von Bernuth, Horst
Lander, Fabian
Weil, Katharina
Hufnagel, Markus
Spiekerkoetter, Ute
Chao, Cho-Ming
Naehrlich, Lutz
Muntau, Ania Carolina
Schulze-Sturm, Ulf
Hansen, Gesine
Wetzke, Martin
Jung, Anna-Maria
Niehues, Tim
Fricke-Otto, Susanne
Von Both, Ulrich
Huebner, Johannes
Behrends, Uta
Liese, Johannes G.
Schwerk, Christian
Drosten, Christian
Von Kries, Ruediger
Schroten, Horst
author_sort Sorg, Anna-Lisa
collection PubMed
description The rate of SARS-CoV-2 infections in children remains unclear due to many asymptomatic cases. We present a study of cross-sectional seroprevalence surveys of anti-SARS-CoV-2 IgG in 10,358 children recruited in paediatric hospitals across Germany from June 2020 to May 2021. Seropositivity increased from 2.0% (95% CI 1.6, 2.5) to 10.8% (95% CI 8.7, 12.9) in March 2021 with little change up to May 2021. Rates increased by migrant background (2.8%, 4.4% and 7.8% for no, one and two parents born outside Germany). Children under three were initially 3.6 (95% CI 2.3, 5.7) times more likely to be seropositive with levels equalising later. The ratio of seropositive cases per recalled infection decreased from 8.6 to 2.8. Since seropositivity exceeds the rate of recalled infections considerably, serologic testing may provide a more valid estimate of infections, which is required to assess both the spread and the risk for severe outcomes of SARS-CoV-2 infections.
format Online
Article
Text
id pubmed-9170697
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-91706972022-06-08 Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021 Sorg, Anna-Lisa Bergfeld, Leon Jank, Marietta Corman, Victor Semmler, Ilia Goertz, Anna Beyerlein, Andreas Verjans, Eva Wagner, Norbert Von Bernuth, Horst Lander, Fabian Weil, Katharina Hufnagel, Markus Spiekerkoetter, Ute Chao, Cho-Ming Naehrlich, Lutz Muntau, Ania Carolina Schulze-Sturm, Ulf Hansen, Gesine Wetzke, Martin Jung, Anna-Maria Niehues, Tim Fricke-Otto, Susanne Von Both, Ulrich Huebner, Johannes Behrends, Uta Liese, Johannes G. Schwerk, Christian Drosten, Christian Von Kries, Ruediger Schroten, Horst Nat Commun Article The rate of SARS-CoV-2 infections in children remains unclear due to many asymptomatic cases. We present a study of cross-sectional seroprevalence surveys of anti-SARS-CoV-2 IgG in 10,358 children recruited in paediatric hospitals across Germany from June 2020 to May 2021. Seropositivity increased from 2.0% (95% CI 1.6, 2.5) to 10.8% (95% CI 8.7, 12.9) in March 2021 with little change up to May 2021. Rates increased by migrant background (2.8%, 4.4% and 7.8% for no, one and two parents born outside Germany). Children under three were initially 3.6 (95% CI 2.3, 5.7) times more likely to be seropositive with levels equalising later. The ratio of seropositive cases per recalled infection decreased from 8.6 to 2.8. Since seropositivity exceeds the rate of recalled infections considerably, serologic testing may provide a more valid estimate of infections, which is required to assess both the spread and the risk for severe outcomes of SARS-CoV-2 infections. Nature Publishing Group UK 2022-06-06 /pmc/articles/PMC9170697/ /pubmed/35668073 http://dx.doi.org/10.1038/s41467-022-30482-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Sorg, Anna-Lisa
Bergfeld, Leon
Jank, Marietta
Corman, Victor
Semmler, Ilia
Goertz, Anna
Beyerlein, Andreas
Verjans, Eva
Wagner, Norbert
Von Bernuth, Horst
Lander, Fabian
Weil, Katharina
Hufnagel, Markus
Spiekerkoetter, Ute
Chao, Cho-Ming
Naehrlich, Lutz
Muntau, Ania Carolina
Schulze-Sturm, Ulf
Hansen, Gesine
Wetzke, Martin
Jung, Anna-Maria
Niehues, Tim
Fricke-Otto, Susanne
Von Both, Ulrich
Huebner, Johannes
Behrends, Uta
Liese, Johannes G.
Schwerk, Christian
Drosten, Christian
Von Kries, Ruediger
Schroten, Horst
Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021
title Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021
title_full Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021
title_fullStr Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021
title_full_unstemmed Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021
title_short Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021
title_sort cross-sectional seroprevalence surveys of sars-cov-2 antibodies in children in germany, june 2020 to may 2021
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170697/
https://www.ncbi.nlm.nih.gov/pubmed/35668073
http://dx.doi.org/10.1038/s41467-022-30482-6
work_keys_str_mv AT sorgannalisa crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021
AT bergfeldleon crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021
AT jankmarietta crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021
AT cormanvictor crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021
AT semmlerilia crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021
AT goertzanna crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021
AT beyerleinandreas crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021
AT verjanseva crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021
AT wagnernorbert crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021
AT vonbernuthhorst crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021
AT landerfabian crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021
AT weilkatharina crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021
AT hufnagelmarkus crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021
AT spiekerkoetterute crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021
AT chaochoming crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021
AT naehrlichlutz crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021
AT muntauaniacarolina crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021
AT schulzesturmulf crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021
AT hansengesine crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021
AT wetzkemartin crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021
AT jungannamaria crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021
AT niehuestim crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021
AT frickeottosusanne crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021
AT vonbothulrich crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021
AT huebnerjohannes crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021
AT behrendsuta crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021
AT liesejohannesg crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021
AT schwerkchristian crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021
AT drostenchristian crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021
AT vonkriesruediger crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021
AT schrotenhorst crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021